Naked Mole Rat Longevity Gene Transferred to Mice Extends Their Lifespan
University of Rochester scientists moved a longevity gene from naked mole rats into mice, boosting lifespan 4.4% and cutting cancer risk.
Summary
Scientists at the University of Rochester took a gene from naked mole rats — animals that live up to 41 years and rarely get cancer — and inserted it into mice. The gene boosts production of high molecular weight hyaluronic acid, a protective molecule that naked mole rats have in abundance. The genetically modified mice lived about 4.4 percent longer than normal mice, showed stronger resistance to tumors, had healthier guts, and displayed lower levels of age-related inflammation. Published in Nature, this study is the first to demonstrate that a longevity trait evolved in one mammal species can be successfully transferred to another, opening a new avenue of research into how we might one day apply similar strategies to human aging.
Detailed Summary
Aging researchers have long been fascinated by naked mole rats, small rodents that can live nearly ten times longer than similarly sized mammals, resist cancer with unusual effectiveness, and avoid many age-related diseases common in other species. Now, for the first time, scientists have taken one of those biological advantages and moved it into another mammal — with measurable results.
The team at the University of Rochester, led by biologists Vera Gorbunova and Andrei Seluanov, engineered mice to carry the naked mole rat version of the hyaluronan synthase 2 gene. This gene drives production of high molecular weight hyaluronic acid, or HMW-HA, a molecule that naked mole rats produce at roughly ten times the levels found in mice and humans. HMW-HA is associated with cancer resistance, reduced inflammation, and protection against age-related cellular damage.
The results, published in Nature in 2023, were encouraging. Modified mice showed a 4.4 percent increase in median lifespan compared with unmodified controls. They also demonstrated stronger tumor resistance, healthier gut tissue, and reduced levels of inflammatory markers — all hallmarks of improved healthspan, not just longer survival.
The study is significant because it establishes a proof of concept: longevity mechanisms that evolved in long-lived species are not locked to those species. They can, at least in principle, be exported. This opens a broader research agenda exploring whether other longevity traits from animals like bowhead whales, Greenland sharks, or other long-lived species could be similarly transferred or mimicked pharmacologically.
Caveats remain significant. A 4.4 percent lifespan extension in mice is modest, and mouse-to-human translation has historically been difficult. Genetic engineering in humans is far from feasible for this application. Still, understanding how HMW-HA confers protection may eventually guide drug or supplement strategies to elevate or mimic its effects in humans.
Key Findings
- Mice engineered with a naked mole rat gene lived 4.4% longer than unmodified control mice
- The transferred gene boosts high molecular weight hyaluronic acid, linked to cancer and inflammation resistance
- Modified mice showed significantly lower tumor rates and healthier gut tissue than controls
- Naked mole rats produce roughly 10x more HMW-HA than mice or humans, a key longevity advantage
- Study proves longevity traits from one mammal species can be functionally transferred to another
Methodology
This is a news summary of a peer-reviewed study published in Nature in 2023, conducted at the University of Rochester by established aging researchers Vera Gorbunova and Andrei Seluanov. The evidence basis is a controlled mouse genetics experiment with lifespan and health outcome measurements. Source credibility is high given the journal, institution, and research team's track record in aging biology.
Study Limitations
The 4.4% lifespan extension in mice is modest and mouse models frequently fail to translate to human outcomes. The article summarizes a 2023 Nature paper without providing full methodological detail, so the primary source should be consulted for sample sizes, controls, and statistical rigor. Human genetic engineering using this approach remains speculative and far from clinical application.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.